CD74 and metastatic melanoma: Indeed, a new 2018 study used the Id-CDR-based peptide, C36L1, which binds to the MIF receptor, CD74, to reactivate macrophages and dendritic cells in both in vitro and in vivo metastatic melanoma models [49].